Oltmans Curtis Gale

Fulcrum Therapeutics, Inc. · Chief Legal Officer

Oltmans Curtis Gale is listed in filings as Chief Legal Officer at Fulcrum Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 4, 2026, including sale activity. Recent filings connect the profile to Fulcrum Therapeutics, Inc. (FULC). The current snapshot covers public activity from Jan 28, 2025 to Feb 4, 2026. Reported amounts are shown as $1.8M to $936.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.